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Abstract

This is a comprehensive study reporting the fabrication of highly porous Gehlenite scaffold (Ca2Al2SiO7)—both
with and without surface modification—for the first time. The sintering temperature of Gehlenite scaffolds was
optimized. Next, the optimized Gehlenite scaffold was coated by polycaprolactone (PCL)-Forsterite (Mg2SiO4)
nanocomposite to improve the scaffold’s brittleness and biological properties. 1375 °C was found to be the
optimized sintering temperature by which the Gehlenite scaffold was consolidated. Different PCL and Forsterite
concentrations were separately applied on the optimized scaffold to yield a complete nanocomposite coating
without clogging the macroporous structure. The bioactivity, degradation rate, cell viability, attachment and
proliferation of three different scaffolds—non-coated (sintered at 1375 °C), PCL-coated and PCL/Forsterite
nanocomposite-coated—were scrutinized and compared to each other in vitro. Based on our results, it is
concluded that the PCL-Forsterite nanocomposite-coated scaffold with desired physical, chemical and biologicalrelated properties has a great potential for bone tissue regeneration.

Keywords
Gehlenite scaffold, Sintering temperature, Surface modification, Forsterite, PCL

1. Introduction
Bone, as a rigid organ composed of an inorganic phase, collagen and water, has both metabolic and
biomechanical roles in the human’s body. Bone is also an adaptive tissue that is able to remodel itself perfectly
when exposed to limited damage or fracture [1]. However, due to either bone tumor removal or traumatic bone
loss, the defect may become a critical size, unable to be healed spontaneously and, therefore, requires medical
intervention; in this situation, clinicians must use bone grafts capable of regenerating the
defect via osteogenesis, osteoconduction and osteoinduction [2,3]. Generally, there are three kinds of bone
grafts—including autografts, allografts and xenografts—but limited quantity and availability, along with negative
side effects of infection and pain, have restricted their application [4]. These grafts are highly applicable, notably
in the case of small defects, not critical size bone damage [5,6]. Therefore, 3D bioactive scaffolds, as a promising
alternative, have developed more effective solutions to regenerate critical size bone defects.
A bone scaffold is regarded as a porous three-dimensional structure providing a temporary support for cell
growth followed by bone tissue regeneration, then finally being reabsorbed [7]. An ideal bone scaffold should
possess some vital physical, chemical and biological properties—among which biocompatibility, biodegradation
in a controlled manner, appropriate surface chemistry, interconnected porous structure, and suitable
mechanical properties can be enumerated [8]. From the material’s science point of view, there are four classes
of biomaterials—metals, ceramics, polymers and composites—to be chosen as a bone scaffold based on the
desired properties [9].
It is well-known that the dominant phase by weight in bone tissue is ceramic-based hydroxyapatite, and it was
proven that bioceramics are able to provide a better environment for osteoblast cells adhesion and proliferation
than other materials [10]. Among different kinds of bioceramics, some of them are already being used in clinics;

these include hydroxyapatite, biphasic calcium phosphates and bioglass, as they are osteoconductive and some
are osteoinductive, as well. However, their application is limited to small bone defects due to their poor
compressive strength and fracture toughness, increasing the risk of these grafts’ failure in the case of loadbearing applications in large defects. Moreover, the mentioned bioceramics have little or no porosity, which is
an important characteristic, as it was proven that interconnected porous structure provides an appropriate
environment for cell attachment, growth and proliferation [11]. Therefore, there is a great need for discovering
more suitable ceramic-based compounds that possess desired mechanical properties and interconnected
porosity simultaneously.
As a promising alternative to calcium phosphates and bioglasses, calcium silicate-based bioceramics (CSBs) have
become the center of attraction among the biomaterials research community since mid-2000s [11]. To be
effectively consolidated and mechanically strong, ceramics require heat treatment at high temperatures
(normally above 1000 °C). However, these temperatures cause traditional bioceramics like hydroxyapatite to
become bioinert, so they are unable to form chemically strong bonds with host bone, leading to loosening and
failure of the bone graft [12]. It is noteworthy that α-calcium silicate—as a member of CSBs family—can be
fabricated into a bulk material and fully sintered at high temperatures without losing its bioactivity property
[13,14]. Moreover, it was proven through previous studies that α-calcium silicate forms a direct bond with host
bone in vivo, followed by bone regeneration [15]. However, α-calcium silicate suffers from two critical problems
preventing it to become a clinically-used product. The first disadvantage is its high degradation rate, which
causes a significant increase in the pH of medium in which it had been implanted; it is critical to consider that a
highly alkaline environment results in cytotoxicity and prevention of the cells’ proliferation [16,17]. The second
limitation factor of α-calcium silicate is its mechanical properties, which is less than the required values for
either cortical or cancellous bone [18]. Therefore, researchers have started to add different metal ions into the
crystal structure of α-calcium silicate to develop new bioceramics with more desirable physical, chemical and
biological properties. Much attention has focused lately on doping Mg, Sr, Zn, Ti and Zr ions into α-calcium
silicate structure, resulting in the development of new class of CSBs, and these bioceramics have shown a
promising potential to be used instead of traditional bioceramics [[19], [20], [21], [22], [23]]. However, very few
studies have been published regarding aluminum-doped calcium silicate, also called Gehlenite, for bone tissue
regeneration.
Gehlenite (Ca2Al2SiO7), with a tetragonal crystal system, belongs to the Melilite group and is categorized under
the umbrella of CSBs family [24]. It has been reported that Gehlenite’s mechanical properties—such as flexural
strength, Young’s modulus and fracture toughness—are much higher than traditional gold standard bioceramics,
like hydroxyapatite and bioactive glass (45S5) [25,26]. Moreover, these values relating to the Gehlenite’s
mechanical properties are higher than those reported for other CSBs including Diopside, Akermanite, Bredigite,
Baghdadite and Hardystonite [11]. In 2016, Roohani-Esfahani et al. [27] adopted solid-state sintering route to
fabricate disk-shaped bodies for bone tissue engineering. Based on their results, Gehlenite has supported
human osteoblast cells attachment and also improved bone-related gene expression. In 2018, our group
reported the synthesis of Gehlenite nanoparticles through sol-gel method, along with its in vitro bioactivity for
the first time [28].
Regardless of the composition of ceramics for bone tissue regeneration, there is an irreconcilable issue limiting
ceramic-based scaffolds; ceramics are naturally brittle and weak in tensile stresses. As it is well-known that bone
consists of a polymer/ceramic nanocomposite, it is much more desirable to mimic the nature of bone for loadbearing scaffolds [29,30]. Therefore, coating of a biocompatible polymer on a sintered porous ceramic scaffold is
an added value to take into account, while still preserving the macroporous structure.
Polycaprolactone (PCL) is a synthetic, biodegradable and biocompatible polymer that has gained a lot of
attention spanning many areas, from agricultural usages to biomedical applications [31]. Although coating of PCL

on a ceramic-based scaffold can significantly increase the mechanical properties of scaffold, the hydrophobic
nature of PCL can negatively affect the scaffold’s bioactivity to induce apatite on itself. Therefore, using a
bioactive filler in combination with PCL is a logical way to overcome the problem by increasing the nucleating
agents on the surface of nanocomposite [32,33].
Magnesium silicate bioceramics (MSBs) have recently been applied in the biomedical field as drug delivery
systems [34,35], bone scaffolds [36] and the surface modifier of biomaterials [37,38]. There are three popular
compounds which can be categorized in the MSBs family including Enstatite, Forsterite and ordered mesoporous
magnesium silicate [39]. Among these compositions, Forsterite—with a chemical formula of Mg2SiO4—belongs
to the Olivine group and has been proven to be both mechanically strong and biocompatible. Moreover,
Forsterite has been assessed carefully in vitro and in vivo and reported to be a high potential bioceramic for
bone tissue regeneration [40,41]. Existence of both Mg2+ and Si4+ ions in the crystal structure of Forsterite has
effective roles in bone development [42,43].
There has been a challenge relating to yielding pure Forsterite nanoparticles through wet chemical synthesis
routes. Previous studies reported that beside formation of Forsterite phase, some impurities like MgO and
Enstatite have the potential to be formed, and through heat treatment at 1200 °C, it will be purified completely
to Forsterite [41,44]. However, raising calcination temperature up to 1200 °C is equal to turning Forsterite
nanoparticles to microparticles. Kharaziha et al. [45] have assessed the effects of particle size on bioactivity and
degradation behavior of Forsterite and indicated that nano-sized Forsterite, unlike the micron-sized, has apatite
formation ability. In our previous study, sol-gel synthesis of Forsterite nanoparticles in acidic medium followed
by calcination at 900 °C was assessed for the first time and the nanoparticles were coated on titanium scaffolds.
Although the yielded nanoparticles were not pure Forsterite, the biological-related properties of coated
scaffolds were excellent [38]. Therefore, developing a one-step synthesis strategy to reach Forsterite
nanoparticles at temperatures below 1000 °C is still challenging and worth researching, because great bioactivity
and biocompatibility can be obtained.
This is a comprehensive study about Gehlenite highly porous scaffolds, with and without surface modification,
for the first time to be applied in bone tissue engineering. The aims are to assess: (1) fabrication of highly porous
Gehlenite scaffolds through polymer sponge technique; (2) applying different temperatures to find a suitable
one which obtains the scaffold with an appropriate mechanical properties and porous structure; (3) assessment
of the effects of sintering temperature on physical, chemical and biological-related properties of the scaffolds in
vitro; (4) surface modification of the scaffold to address its brittleness, mainly through optimizing the coating’s
weight ratios; (5) comparing non-coated, polymer-coated and polymer-ceramic nanocomposite-coated scaffolds
to carefully realize the effects of each part of coating on the physical, chemical, and biological-related properties
of the scaffolds in vitro.

2. Materials and methods
2.1. Synthesis of gehlenite nanoparticles

The Gehlenite nanoparticles were synthesized through sol-gel method, just like our previous study [28]. Briefly,
tetraethyl orthosilicate (TEOS, Merck, Germany) was hydrolyzed into a mixture of deionized water and nitric acid
(2 M HNO3) for 30 min, followed by addition of Ca(NO3)2.4H2O (Merck, Germany) and Al(NO3)3.9H2O (Merck,
Germany) one after another (TEOS/H2O/HNO3/Al(NO3)3.9H2O/Ca(NO3)2.4H2O = 1:8:0.16:2:2). The mixture was
kept under vigorous stirring for 5 h. Next, it was aged in an oven at 60 °C for 24 h, followed by drying at 120 °C in
the oven for another 48 h. The dried gel was finally ground, sieved and calcined at 1300 °C with 10 °C min−1 heat
rate for 3 h. Additionally, ball milling was accomplished for calcined Gehlenite powders to remove any possible
agglomeration, and the ratio of ball/powder was set on 10/1, time: 8 h and rotational speed: 250 rpm.

2.2. Fabrication of nanostructured gehlenite scaffolds

The polymer sponge was adopted to fabricate Gehlenite scaffolds because the pore structure and connectivity
of polyurethane sponge as the sacrificial agent in this technique can mimic the nature of cancellous bone
perfectly [46,47]. This technique is based on using an appropriate binder to prepare a well-dispersed slurry
containing Gehlenite nanoparticles. Herein, polyurethane sponge (MEAY, China) with a pore size in the range of
300−700 μm was used, and the foams were cubically cut (10 × 10 × 5 mm) followed by washing them carefully
with distilled water and ethanol to remove contaminants.
Carboxymethyl cellulose (1 wt.%, Merck, Germany) was first dissolved into a deionized water solution at 40 °C,
then the Gehlenite nanoparticles (20 wt.%) were slowly added to the solution under vigorous stirring to prepare
the slurry. The slurry was preserved under the same conditions for 5 h to ensure that a complete dispersion was
achieved. Next, the cubic polyurethane sponges were immersed into the slurry and kept immersed for full
impregnation, then they were removed and slightly squeezed to eliminate the extra slurry in order to prevent
clogging of the porous structure. The impregnated foams were transferred into an oven and kept at 40 °C for
48 h for drying, then placed into an electric furnace for sintering using a multi-stage schedule described as
follows: (I) raising the temperature with 1 °C min−1 heating rate to 600 °C; (II) keeping the scaffolds at the same
temperature for 1 h to remove the remained carbon; (III) applying 2 °C min−1 heating rate up to 1350, 1375 and
1400 °C to assess the sintering behavior of scaffolds; (IV) preserving the scaffolds at the mentioned
temperatures for 3 h; (V) and finally decreasing the temperature with 5 °C min−1 cooling rate to the room
temperature.

2.3. Synthesis of forsterite nanoparticles

Forsterite nanoparticles were chosen in the present study as the ceramic part of composite coating on the
Gehlenite scaffolds. The Forsterite nanoparticles were synthesized through surfactant-assisted sol-gel method in
an alkaline medium according to our previous study with some modifications [34]. A solution containing
deionized water (65 mL) and ethanol (15 mL) was first prepared and cetyltrimethylammonium bromide (1.3 g,
CTAB, Merck, Germany) was dissolved into the solution. Next, magnesium nitrate hexahydrate (12.3 g,
Mg(NO3)2.6H2O, Merck, Germany) and tetraethyl orthosilicate (5.4 mL, TEOS, Merck, Germany) were added, one
after another, based on the molar ratio of Forsterite. The solution was preserved for 3 h in order to become
homogeneous, then an appropriate amount of ammonia solution (NH4OH, Merck, Germany) was added
dropwise to the solution and the pH was set at 9. Addition of NH4OH was accompanied by precipitation of the
precursors, and the color of solution became milky. The mixture was kept under vigorous stirring for 5 h, then
aged for 24 h at 60 °C without stirring. The suspension was filtered followed by drying into an oven for another
24 h at 80 °C. The dried powder was heat treated into an electric furnace at 900 °C for 3 h with a 10 °C
min−1 heating rate.

2.4. Surface modification of gehlenite scaffolds

To modify the surface of Gehlenite scaffolds, the combination of PCL and Forsterite nanoparticles was used
because of the great potential of both compounds in bone tissue regeneration. It is critical to bear in mind that
the concentration of both polymer and ceramic in the composition of surface coating has an impactful role in
the success of bone scaffold. Therefore, in the present study, the Gehlenite scaffolds were first coated with
different PCL concentrations—including 4, 6, 8 and 10 wt.%—to find an optimized concentration that did not
clog the maroporous structure and simultaneously covered the scaffold’s surface. PCL pellets (Mw = 80,000,
Sigma Aldrich, USA) were dissolved into chloroform (Sigma Aldrich, USA) at the mentioned concentrations, and
the Gehlenite scaffolds were then coated through dip coating technique followed by applying a low vacuum.
Nonetheless, Forsterite nanoparticles with different concentrations were assessed into the optimized PCL
solution.

Our main goal to assess different Forsterite weight ratios was to coat the maximum amounts of the ceramic
nanoparticles without clogging the macropores of the scaffold. Therefore, Forsterite nanoparticles with 5, 7, 9
and 11 wt.% ratios were used to optimize the ceramic’s concentration. It should be mentioned that the ceramic
nanoparticles were first dispersed into chloroform for 3 h under vigorous stirring, then added to PCL solution.
The coated scaffolds were dried in a vacuum oven at 40 °C for 48 h.

2.5. Characterization

Different characterization techniques were adopted in this study to characterize the physical and chemical
properties of Gehlenite nanoparticles, non-coated (sintered at 1350, 1375 and 1400 °C), PCL-coated, and
PCL/Forsterite nanocomposite-coated scaffolds, along with Forsterite nanoparticles. X-ray diffraction (XRD,
Philips TW3710, Netherlands) was applied to assess the crystal structures of samples. Field-emission scanning
electron microscopy (FESEM, SU3500, Hitachi, Japan), equipped with energy dispersive spectroscopy (EDS) and
transmission electron microscopy (TEM, JEM-100CX, Japan), were applied to evaluate the morphology, particle
size and elements of Gehlenite and Forsterite nanoparticles. The microstructural studies of all scaffolds were
accomplished by SEM (VEGA-TESCAN-XMU, Czech Republic) equipped with EDS. To assess the chemical bonds of
samples, Fourier transform infrared spectroscopy (FTIR, JAS-CO6300) was applied. The textural properties of
Forsterite nanoparticles—such as surface area, pore size distribution and pore volume—were assessed through
N2 adsorption-desorption (NOVA-2000) using BET (Brunauer- Emmett-Teller) and BJH (Barrett-Joyner-Halenda)
methods.
A computer controlled universal testing machine (Instron Wolpert, Darmstadt, Germany) with a crosshead
speed of 0.5 mm min–1 was applied to measure the compressive strength of samples, including non-coated
(sintered at 1350, 1375, and 1400 °C), PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds. Three
similar scaffolds for each sample were used, and the results are based on mean ± SD.
The porosity of non-coated (sintered at 1350, 1375 and 1400 °C), PCL-coated and PCL/Forsterite nanocompositecoated scaffolds was measured based on Archimedes formula as follows:(1)P=W2-W1W2-W3where W1 relates
to the weight of scaffold before immersion into water, W2 relates to the weight of scaffold after immersion into
water, and W3 is the weight of scaffold during suspension into water. In the case of porosity measurement,
three similar scaffolds were used, and the results are based on mean ± SD.

2.6. Bioactivity

In vitro bioactivity is a primitive test by which bone bonding ability of a novel biomaterial can be estimated [48].
Deposition of carbonated calcium phosphate on the surface of biomaterials is an evidence demonstrating their
bioactivity potential for further considerations [49]. Herein, the in vitro bioactivity of Gehlenite scaffolds—which
had been sintered at 1350, 1375 and 1400 °C—was first assessed through immersion of the scaffolds into
simulated body fluid (SBF) up to 21 days. Next, the optimized scaffold, which had appropriate physical, chemical,
and biological-related properties, was coated with PCL and PCL/Forsterite nanocomposite and soaked into SBF
up to 21 days. Nonetheless, the in vitro bioactivity of non-coated, PCL-coated and PCL/Forsterite
nanocomposite-coated scaffolds was also assessed up to 7 days into Dulbecco's Modified Eagle Medium
(DMEM-low + 10 % FBS + 1 % penestrep, Sigma Aldrich, USA). Additionally, non-coated, PCL-coated and
PCL/Forsterite nanocomposite-coated scaffolds were carefully compared to each other for better understanding
coating’s composition effects. The SBF was prepared based on the Kokubo’s protocol [50]. Eq. (2) was used to
calculate the volume of SBF for scaffolds as follows:(2)Vs=Sa10where Sa is the surface area of the scaffold (mm2)
and Vs is the SBF volume (mL). After pouring SBF on the scaffolds, they were kept in an incubator at 37 °C up to
21 days. After the intended time interval, the scaffolds were removed and rinsed with deionized water and dried
in an oven for 72 h at 37 °C. The pH of each SBF solution during the test was carefully determined. Moreover, to
find out the ions exchange during the test, the ions concentrations were measured by inductively coupled

plasma (ICP, Varian BV ES-700, Australia). It should be noted that the results of the pH variations and ICP are
based on mean ± standard of three samples.

2.7. Degradation

Among different properties of a ceramic scaffold for bone tissue regeneration, degradation rate as an essential
factor should be carefully assessed in vitro. To assess the degradation behavior of scaffolds, phosphate buffer
saline (PBS, pH = 7.4) and citric acid buffer (CAB, pH = 3) were used. In the first step, the scaffolds were
meticulously rinsed with both ethanol and distilled water to remove any potential contamination, followed by
drying in an oven at 40 °C for 48 h. Eq. (2) was used to calculate the volume of each buffer for the test. In this
test, the scaffolds’ weight variation percentage (%) was estimated through removing each scaffold at the
intended time interval, followed by rinsing with distilled water and drying in an oven for 2 h and returning it
back into the solution. The weight variation percentage (%) of each scaffold is according to the initial weight of
scaffold before soaking into the buffers. The pH variation was also determined and the results of both weight
variation percentage (%), and pH variations are based on mean ± standard of three scaffolds.

2.8. Cell compatibility
2.8.1. MTT assay
Dimethylthiazoldiphenyltetrazolium bromide (Sigma Aldrich, USA) assay, which is generally known as MTT assay,
was adopted to determine the cell viability of scaffolds. The cell viability of scaffolds was assessed up to 7
days in vitro, and the cell line was MG63 provided from National Cell Bank of Iran, Pasteur Institute of Iran. The
culture process and precursors are identical to our previous study, in which every step is carefully described
[51].

2.8.2. Cell attachment and proliferation
The cell attachment was first assessed for Gehlenite scaffolds sintered at 1350, 1375 and 1400 °C up to 24 h to
determine the effects of sintering temperature on the cells’ attachment. In the case of PCL-coated and
PCL/Forsterite nanocomposite-coated scaffolds, the cell attachment and proliferation were assessed up to 7
days. Therefore, a PBS solution containing 2.5 wt.% Glutaraldehyde (Sigma, USA) was prepared, and 500 μL of
this solution was added to the cell culture mediums—which included the scaffolds—for the fixation process,
followed by keeping them into a refrigerator for 3 h. Afterwards, the Glutaraldehyde solution was removed from
the cell culture mediums, and the scaffolds were dehydrated by 60, 70, 80, 90 and 100 % ethanol solutions.

2.8.3. Cell staining
In the case of non-coated, PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds, DAPI (4′, 6diamidino-2-phenylindole) staining as a fluorescent stain was used to assess live and fixed cells on the scaffolds.
DAPI staining was accomplished in this study after 1 and 7 days as a complementary test to the cell attachment
and proliferation. The MG63 cells were first fixed by 4 wt.% paraformaldehyde, rinsed with PBS, then
permeabilized in PBS by 0.1 wt.% Triton X-100. The non-coated, PCL-coated and PCL/Forsterite nanocompositecoated scaffolds were rinsed again with PBS and stained with 0.1 μg/mL of DAPI, followed by final observation
through the fluorescent image analyzer (Olympus, DP72, Japan).

2.9. Statistical analysis

For statistical analysis, the SPSS software was applied through one-way analysis of variance with the level of
statistical significance of P ≤ 0.05.

3. Results and discussion
3.1. Characterization of gehlenite nanoparticles

The Gehlenite nanoparticles’ structure and microstructure were characterized through XRD, FESEM and TEM.
The XRD patterns of Gehlenite nanoparticles and Gehlenite JCPDS pattern (01-075-1677) are indicated in Fig.
1(a), where it is observable that pure Gehlenite structure, without any undesired phase, is obtained. Fig. 1(b)
and (c) show the FESEM and TEM micrographs of Gehlenite nanoparticles, respectively. It was found that very
small spherical particles in the range of 10−20 nm were acquired. Of note is that due to the small particle size
and the high tendency of nanoparticles to decrease their surface energy [52], the Gehlenite nanoparticles in
FESEM micrograph are seen in the form of agglomerated particles. However, because of dispersing the
Gehlenite nanoparticles into ethanol in TEM technique before taking the micrograph, the nanoparticles are well
dispersed in Fig. 1(c), proving both the spherical morphology and particle size. Jia et al. [53] in 2007 adopted a
synthesis method, called the PVA method, through which Gehlenite micron-sized particles with flakey shapes
were obtained. Roohani et al. [27] used wet attrition milling to mix the Gehlenite precursors, leading to pure
Gehlenite particles. However, neither the Gehlenite particles’ size nor morphology was reported. It can be
deduced that sol-gel method, which was adopted in the present study, has potential to yield Gehlenite particles
in nanometer range with spherical morphology. Nonetheless, Fig. 1(d) exhibits the elemental mapping of
Gehlenite nanoparticles and well dispersed elements—including Al, Si, Ca and O—are observable.

Fig. 1. The XRD pattern of Gehlenite nanoparticles (a), the FESEM micrograph of Gehlenite nanoparticles (b), the
TEM micrograph of Gehlenite nanoparticles (c) and the elemental mapping of Gehlenite nanoparticles (d).

3.2. Gehlenite scaffolds

Turning a novel nanostructured bioceramic into a bone scaffold in the first step requires simultaneous desirable
mechanical properties and interconnected macroporosity. It is well-known that, generally, ceramics should be
sintered in temperatures above 1000 °C to become mechanically strong from load-bearing applications’
viewpoint. Besides, increasing in the sintering temperature is synchronized with a significant decrease in total
porosity of the scaffold. Therefore, optimization of a novel ceramic scaffold’s sintering temperature to obtain
both desirable mechanical properties and porosity is of great concern. In this section, the effects of sintering
temperatures including 1350, 1375, and 1400 °C on the structure, microstructure, compressive strength and
porosity of Gehlenite scaffolds are discussed. Fig. 2(a–f) provides the SEM micrographs with EDS analyses, XRD
patterns, compressive strength, porosity and a digital photograph of Gehlenite scaffolds (sintered at 1350, 1375
and 1400 °C). It is noteworthy that choosing a range of temperature between 1350−1400 °C rooted in our early
observations; for instance, 1300 °C was also applied, but the scaffold was very brittle to handle, so the lowest
temperature to get the study started with was 1350 °C.

Fig. 2. The digital camera photograph of Gehlenite scaffolds sintered at 1350, 1375 and 1400 °C (a); the SEM
micrographs and EDS analyses of Gehlenite scaffolds sintered at 1350 °C (b-b4), 1375 °C (c-c4) and 1400 °C (d-d4);
the XRD patterns of Gehlenite scaffolds sintered at different temperatures (e); the compressive strengths and
porosities of Gehlenite scaffolds sintered at different temperatures (f).
Fig. 2(a) shows the digital photograph of Gehlenite scaffolds sintered at different temperatures, and it is clear
that increasing in the sintering temperature was accompanied with a significant decrease in the size of scaffolds.
The effects of temperature on the microstructure of scaffolds are provided in Fig. 2(b-d4), where the scaffold
sintered at 1350 °C has a porous structure mostly in the range of 200−500 μm. Fig. 2(b3) clearly indicates that
the struts were not fully sintered and, besides the mentioned pore size (200−500 μm), there were quite number
of smaller porosities in the range of 2−10 μm. Interestingly, raising the temperature up to 1375 °C caused the
smaller porosities (2−10 μm) to be clogged due to particles’ growth, and also the size of pores with honeycomb
structure (200−500 μm) was reduced (Fig. 2(c-c3)) [54,55]. Applying 1400 °C to the scaffolds led to some
deformation, as can be seen in Figure (d-d3). This sintering temperature seems to be the maximum for the
Gehlenite scaffolds because it is visible that honeycomb pores (200−500 μm) disappeared and were substituted
with irregular pores in the size of up to 1 mm. Moreover, the struts were significantly thickened and, through
higher magnifications, it is observable that the grains were integrated and the grain boundaries are
indistinguishable, meaning a complete sintering was obtained. Nonetheless, Fig. 2(b4, c4 and d4) exhibits the EDS
analyses of Gehlenite scaffolds, where Al, Si, Ca and O were detected as the elements of Gehlenite without any
undesired element, except Au belonging to imaging process. Fig. 2(e) exhibits the XRD patterns of Gehlenite
scaffolds sintered at different temperatures. Taking XRD from the scaffolds helps us to ensure that no

undesirable phase was formed after sintering at 1350, 1375 and 1400 °C, and the scaffolds were composed of
pure Gehlenite phase. Fig. 2(f) relates to the compressive strength and porosity of Gehlenite scaffolds. Based on
the Archimedes formula (Eq. (1)), the porosity of scaffolds sintered at 1350, 1375 and 1400 °C was 90 ± 2,
81 ± 3.2 and 43 ± 1.6 %, respectively. Moreover, the compressive strengths of scaffolds sintered at 1350, 1375
and 1400 °C are 0.08 ± 0.06, 0.7 ± 0.09 and 5.65 ± 0.1 MPa, respectively. The results are in good agreement with
the SEM micrographs.
As discussed before, besides the porous structure in the range of 200−500 μm, the whole body of scaffold
sintered at 1350 °C contained lots of pores in the range of 2−10 μm, leading to very weak compressive strength
(0.08 ± 0.06 MPa) and 90 % porosity. It is well-known that there is a reverse relationship between total porosity
(%) and compressive strength [47]. The increase in sintering temperature up to 1375 °C was synchronized with
clogging the pores in the range of 2−10 μm, yielding a nearly nine-fold increase in the compressive strength of
this scaffold compared to the former scaffold (1350 °C). Interestingly, just 9 % of porosity was reduced by the
sintering at 1375 °C. In the case of sintering at 1400 °C, it was found that the total porosity and compressive
strength were 43 ± 1.6 % and 5.65 ± 0.1 MPa, respectively. This change in both values is regarded very important
because on one hand, attaining a compressive strength around 5.65 MPa was an advantage, while on the other
hand, the price of gaining that compressive strength was the reduction in total porosity of scaffold due to
sintering at 1400 °C, which is a huge disadvantage in the case of porous bone scaffold. The total porosity over 70
% with interconnected structure guarantees the diffusion of nutrients and removal of waste producing by
osteoblast cells [7,56]. Therefore, from this section, it can be determined that the scaffold sintered at 1375 °C
had more suitable physical properties as a porous bone scaffold than the other scaffolds.

3.3. In vitro bioactivity

Speaking of reactivity, bioceramics are categorized as bioinert, bioactive and biodegradable based on their
reaction to the medium in which they are implanted. In the case of bone scaffolds, this class of materials should
possess bioactivity potential, which means an occurrence of ions exchange between the scaffold and its
surrounding medium to induce carbonated-calcium-phosphate deposition, along with exhibiting desired
mechanical properties. The newly formed calcium phosphate has the potential to make a strong bonding with
the host bone [57,58].
The effects of sintering temperature on in vitro bioactivity potential of the Gehlenite scaffolds were assessed up
to 21 days into SBF and indicated in Fig. 3. This figure contains the SEM micrographs of scaffolds with different
sintering temperatures after 7, 14 and 21 days’ immersion into SBF. Moreover, the EDS analyses were taken
from those scaffolds, which were soaked up to 21 days into SBF. It is noteworthy that the ions concentrations
and pH variations during bioactivity test were assessed and displayed in Fig. 4. Fig. 3(a-c2) shows the surface of
Gehlenite scaffold sintered at 1350 °C after 7 (Fig. 3(a and a1), 14 (Fig. 3(b and b1) and 21 (Fig. 3(c and c1) days
soaking into SBF. It is obvious that from the early days of immersion into SBF, newly formed precipitates were
deposited on this scaffold, and increase in soaking time was accompanied by more accumulation and
densification of the precipitates. Fig. 3(c2) provides the EDS analysis of scaffold (1350 °C) after 21 days of soaking
into SBF, where the main elements of Gehlenite structure—Ca, Al, Si and O—were detected, along with P.
However, the other scaffolds sintered at 1375 and 1400 °C experienced a different surface reactivity after being
soaked into SBF.

Fig. 3. The SEM micrographs and EDS analyses of Gehlenite scaffolds sintered at 1350 °C (a-c2), 1375 °C (d-f2) and
1400 °C (g-i2) after soaking in simulated body fluid for different time periods.

Fig. 4. The plots of Al3+ (a), Ca2+ (b), Si4+ (c) and PO43− (d) ion concentrations and pH variations (e) of Gehlenite
scaffolds sintered at different temperatures in simulated body fluid for different time periods.
Fig. 3(d-f1) clearly shows that the Gehlenite scaffold sintered at 1375 °C, even after 21 days soaking into SBF, was
not successful to completely cover its surface by newly formed calcium phosphate precipitation. Taking an EDS
analysis from the precipitates revealed that P was detected besides the other elements (Fig. 3(f2)). In the case of
Gehlenite scaffolds sintered at 1400 °C, the same scenario was repeated, but it seems that the calcium
phosphate deposition was even less than the scaffold sintered at 1375 °C (Fig. 3(g-i1)), and through Fig. 3(i2)—
relating to the EDS analysis of scaffold (1400 °C)—P and the other elements were detected, similar to the other
scaffolds. It is clear that the increase in sintering temperature caused the scaffolds to become less reactive into
SBF.

Surface reactivity is a governing factor determining if a bioceramic is bioactive. Through a sintering process near
the melting temperature, the surface of ceramic particles starts to soften and a much easier diffusion occurs. As
the result, a connection between two neighboring particles occurs causing a neck formation. The sintering
process is synchronized with an increase in the density and a clear decrease in the total porosity. The higher
total porosity is proven to provide more surface functional groups (OH−), which have an essential role for a
bioceramic to be considered bioactive [[59], [60], [61]].
Through Fig. 4, which contains the release and consumption plots of different ions during the soaking period, it
can be better understood what exactly happens when the Gehlenite scaffolds with different sintering
temperatures were soaked into SBF. Fig. 4(a, b, c, and d) exhibits Al3+, Ca2+, Si4+ and PO43− concentrations at
different time intervals. In the case of Al3+, Ca2+ and Si4+ ions, an upward trend with more intensity up to 14 days
is clear, followed by a less aggressive trend up to 21 days soaking into SBF. On the other hand, the scenario is
the reverse for PO43− trends, which experienced a whole downward trend up to 21 days; this occurrence was
due to the constant consumption of PO43− ions during immersion period to form calcium phosphate particles on
the surface of scaffolds.
In the previous section (Fig. 2(b2 and b3), it was discussed that the scaffold sintered at 1350 °C had a quite
number of small porosities in the range of 2−10 μm. It was reported that more porosity, specifically in the
mentioned range, can effectively improve surface reactivity leading to more ions release [7,62]. Therefore, it can
be inferred that more porosity in the scaffold sintered at 1350 °C led to the more ions release yielding more
newly formed calcium phosphate deposition into SBF. It should be mentioned that the pH variations up to 21
days are indicated through Fig. 4(e), where the scaffold sintered at 1350 °C exhibited a fast increasing rate up to
7 days, followed by adopting a steady state up to 21 days and finally reaching a pH of 8. This pH increment,
which was the most among the all scaffolds, was due to higher release rate of both Al3+ and Ca2+, which were
reported to have great potential to increase the pH towards an alkaline medium [63,64]. The pH increment up to
8 means more available OH− ions are ready to go through reaction with the other ions, which is why in the case
of scaffold sintered at 1350 °C, both faster and more precipitation all over the scaffold have occurred. From this
section, it can be concluded that the scaffold sintered at 1350 °C had better bioactivity potential than the other
scaffolds, and the increase in sintering temperature of Gehlenite scaffolds had a reverse relationship with
bioactivity potential and yielded the nearly bioinert scaffold.

3.4. In vitro degradation

For a novel ceramic-based bone scaffold that is fabricated and designed to regenerate a bone defect in a desired
rate, evaluation of its degradation rate in vitro is of great significance. Generally speaking, degradation is a
process in which an implanted material starts to decompose to its simpler components after being in contact
with different biological mediums. The implanted material undergoes physical and chemical changes, among
which variation in size, weight, density and porosity can be observed. Moreover, degradation is synchronized
with the release and consumption of different ions, leading to a shift to pH of the material’s environment [65].
Therefore, assessment of degradation behavior and its effects on the physicochemical properties of bone
scaffold after soaking into simulated biological environments leads to a deeper understanding about the
applicability of scaffold. Herein, the Gehlenite scaffolds sintered at 1350, 1375 and 1400 °C were immersed into
two buffers, including PBS and CAB.
Before getting involved in this section, the reason behind using CAB (pH = 3) should be cleared. It was reported
that after full differentiation of an osteoclast cell, it attaches to bone surface and then starts to establish a
microenvironment between itself and the host bone, followed by pumping H+ ions in order to acidify the
microenvironment, which eventually results in bone mineral dissolution [10,66]. Therefore, it seems necessary
to simulate the acidic medium in vitro by using CAB to assess the effects of H+ ions on the degradation behavior

of Gehlenite scaffolds. The weight variation percentage (%) of Gehlenite scaffolds sintered at 1350, 1375 and
1400 °C after being soaked into PBS and CAB, plus the pH variations in the both buffers were assessed in
vitro and exhibited in Fig. 5.

Fig. 5. The weight variation percentage (%) of Gehlenite scaffolds sintered at different temperatures and pH
changes during soaking into phosphate buffer saline (a and b) and citric acid buffer (c and d) at different time
intervals.
Fig. 5(a) shows the weight variation percentages (%) of scaffolds into PBS; the scaffold’s weight sintered at
1350 °C after 7 days soaking into PBS increased up to nearly 120 % from 100 %, which can be caused by
deposition of newly formed precipitations. Then, this scaffold experienced an intense reduction in its gained
weight after 14 days soaking followed by a constant and slow reduction in its weight. Finally, this scaffold lost 5
% of its initial weight after 28 days. The other two scaffolds soaked into PBS did not exhibit a significant change
in their weights. The scaffold sintered at 1400 °C only showed less than 1 % reduction in its initial weight, while
the scaffold sintered at 1375 °C increased its weight by about 3 % after 21 days, followed by losing it after 28
days soaking into PBS.
The pH variation in PBS, which is indicated through Fig. 5(b), revealed that all scaffolds had an aggressive pH plot
reaching above 8 after 28 days soaking. A comparison between the pH variations in SBF (Fig. 4(e)) and the pH
variations here provides interesting information. From Fig. 4(e), it can be seen that there is a significant
difference between the pH of SBF and PBS. It is pretty obvious that the only difference between these solutions
is the existence of more ions in SBF than PBS. After immersion of the scaffolds into either SBF or PBS, there are
mainly two reactions competing with each other, including ions release and consumption. In the case of SBF, it
was reported that once super saturation occurs, the deposition starts to form on the scaffolds. Because of the
existence of Ca2+ and Mg2+ ions in the initial recipe of SBF, the super saturation occurs faster than PBS leading to
a less increase in the pH of SBF [39,41]. It was previously reported that an increasing in pH towards a highly
alkaline medium results in a cytotoxicity, so it was recommended to take control over the pH of scaffold for
bone tissue regeneration [67].

Through Fig. 5(c and d), the weight variation percentage (%) of scaffolds and the pH variations into CAB are
shown, where the scaffolds sintered at 1350, 1375 and 1400 °C lost nearly 90, 70, and 40 % of their initial weight
after 28 days soaking into CAB, respectively. The pH values of scaffolds exhibit a burst increase in early days of
soaking, followed by an aggressive trend up to 28 days. From this section, it can be concluded that the increase
in sintering temperature of Gehlenite scaffolds led to a decrease in its degradation behavior. Moreover, the
Gehlenite scaffolds tended to be more degraded in acidic mediums in which the macrophages and osteoclast
cells acidify the local microenvironments of the scaffolds [66].

3.5. In vitro cell compatibility and attachment

Through the MTT assay, the cell viability of Gehlenite scaffolds sintered at 1350, 1375 and 1400 °C was assessed
up to 7 days in vitro. Moreover, the cell attachment on the scaffolds was assessed after 7 days, and the
morphology of attached cells was observed through SEM. The cell viability values of scaffolds after 1, 3 and 7
days are exhibited in Fig. 6(a). This figure demonstrates that the cell viability of scaffolds on the first day was
higher than the negative-control (the cell culture without being exposed to the scaffolds), showing that the
scaffolds did not affect the cells in a negative way, but furthermore, they provided a more suitable environment
for the proliferation of cells than the negative-control. Continuing the MTT test up to 3 days was similar to the
first day, which showed an increase in the cell viability compared to the negative-control. Finally, the same
scenario was repeated again on the seventh day.

Fig. 6. The cell viability of MG63 cells after 1, 3 and 7 days of incubation on Gehlenite scaffolds sintered at
different temperatures (a); the SEM micrographs of MG63 attachment to the Gehlenite scaffolds sintered at
1350 °C (b and b1), 1375 °C (c and c1) and 1400 °C (d and d1) after 7 days (one-way ANOVA, black star denotes
P ≤ 0.05).
In the structure of Gehlenite scaffolds, Al3+ ions have the most potential to affect osteoblast-like cells in an
adverse way when their concentration goes beyond the tolerance of the cell line. Therefore, the ICP was
adopted to determine the ions concentrations of cell culture mediums after 7 days. Interestingly, the results
showed that the degradation rates in the cell culture medium were more than the in vitro bioactivity (Fig. 4).
The data shown in Table 1 demonstrated that Al3+ ions concentrations were 0.04, 0.032 and 0.028 mg/L for the
scaffolds sintered at 1350, 1375 and 1400 °C, respectively. The mentioned amounts are comparatively higher
than the ICP data shown in Fig. 4. This is the case for Ca2+ and Si4+ ions as well. It was reported that the cell
culture medium is more aggressive than SBF due to existence of sugar, proteins, etc. Moreover, during
incubation period, a continuous change between the scaffold’s interface and cells occurs, which may have an
impact on the scaffold’s degradation behavior [68]. The IC50 of Al3+ ions was previously reported and carefully
assessed when they were exposed to MG63 cell line; the results indicated that the Al3+ concentration should be
at least 10 mM to induce toxicity and reduce the MG63 cells down to 50 % [69]. Herein, it is visible that even in
the cell culture medium, which caused more degradation in the structure of scaffolds, the Al3+ concentration in

mM was about 0.0012, which is significantly less than 10 mM. Therefore, it can be deduced that without
considering the effects of sintering temperature on the different properties of Gehlenite scaffolds, all of them
are considered cell compatible to MG63 in vitro.
Table 1. The ions concentrations of Gehlenite scaffolds sintered at different temperatures in the cell culture
medium after 7 days.
Sintering temperature (ºC) Ca2+ (con. mg/L) Al3+ (con. mg/L) Si4+ (con. mg/L)
1350
113.4
0.04
23.81
1375
104
0.032
20.55
1400
83.96
0.028
15.77
The SEM micrographs attributing to the cell attachment on scaffolds are indicated through Fig. 6(b-d1). It is
noteworthy that the cell attachment for the Gehlenite scaffolds sintered at 1350, 1375 and 1400 °C was
assessed after 7 days and for each scaffold, and two micrographs are provided in order to better understand the
cells morphologies on the scaffolds. A general phenomenon is observable relating to the cells morphology on
the scaffolds—the cells are huge and well-spread. In previous studies, it was discussed that on the first days of
cell culture, the cell morphology was mostly spherical, and these cells were distributed all over the surface in a
sporadic way. However, an increase in the cell culture time up 7 days was accompanied by joining the single cells
to each other to form a bigger and more uniform matrix [70,71]. As the result of cell attachment study, it can be
said that the Gehlenite scaffolds sintered at different temperature provide an appropriate surface for the cells
fixation and proliferation in vitro.
As mentioned in the previous sections, the present study is a comprehensive one that focuses on revealing
Gehlenite scaffold’s potential in bone tissue regeneration for the first time. In the first step, effects of sintering
temperature on the physical, chemical and biological-related properties of Gehlenite scaffolds were carefully
assessed. It was revealed that the increase in sintering temperature significantly affected the scaffold’s porosity
and compressive strength. The scaffold sintered at 1350 °C had the highest porosity percentage among the
scaffolds, but its compressive strength was very weak, even for handling—let alone implantation. On the other
side, sintering at 1400 °C endowed the scaffold significantly higher compressive strength than the other
scaffolds. However, the total porosity of this scaffold was sacrificed and fallen below the desired range for bone
tissue regeneration due to more densification at the mentioned temperature. Therefore, the scaffold sintered at
1375 °C—by having both suitable porosity and compressive strength—was chosen to be the optimized sample,
but this scaffold suffered from weak bioactivity (Fig. 3), limiting its potential for bone tissue regeneration.
Moreover, the ceramic-based scaffolds’ disadvantage is their brittleness, which can be compensated through
using a polymer to improve the scaffolds mechanical properties. Hence, it was decided to modify the surface of
Gehlenite scaffold sintered at 1375 °C with a polymer-ceramic nanocomposite to not only improve the scaffold’s
mechanical properties, but also its bioactivity potential in vitro.

3.6. Forsterite nanoparticles

The Forsterite nanoparticles were synthesized here to be used in the surface modification of Gehlenite scaffold
sintered at 1375 °C (the optimized scaffold) in combination with PCL. This section focuses on the synthesis and
sole characterization of Forsterite nanoparticles. The nanoparticles were synthesized through CTAB-assisted solgel method and characterized through XRD, N2 adsorption-desorption, FESEM equipped with EDS and TEM (Fig.
7). Fig. 7(a) indicates the XRD pattern of Forsterite nanoparticles, which is set above the XRD pattern of
Forsterite (JCPDS pattern 00-003-1117). As seen, the synthesized Forsterite nanoparticles’ XRD pattern is
completely compatible with the JCPDS pattern, proving well-crystallization of the nanoparticles at 900 °C
without existence of an undesired phase. Fig. 7(b) contains the N2 adsorption-desorption isotherm of

nanoparticles plus the pore size distribution. N2 adsorption-desorption normally determines the textural
properties—including surface area, pore volume and pore size. Through IUPAC classification, the Forsterite
nanoparticles’ isotherm is similar to type IV, and by looking at the hysteresis, it can be deduced that this kind of
pattern was observed in mesoporous materials whose mesoporous structure formed due to agglomeration of
particles leading to slit-shaped pores [72]. The textural properties of Forsterite nanoparticles were a surface
area of 17.71 m2/g and pore volume of 0.15 cm3/g. The pore size distribution was calculated by adsorption
branch of BJH method, and it was found that the Forsterite nanoparticles had a bimodal mesoporous structure
in the range of 1.88–2.41 nm and 19–25.8 nm. Fig. 7(c and d) shows the microstructure of Forsterite
nanoparticles through FESEM and TEM, where the FESEM micrograph exhibits that the particles were
aggregated and their morphology was spherical. The TEM micrograph clearly indicates the spherical particles
with sizes in the nanometer range (< 100 nm). The elemental mapping was also adopted to show the
distribution of Mg, Si and O all over the surface (Fig. 7(e-e3)). These figures (Fig. 7(e-e3)) revealed well-dispersion
of the elements and proved the purity of Forsterite nanoparticles.

Fig. 7. The XRD pattern (a), N2 adsorption-desorption isotherm with pore size distribution (b), FESEM micrograph
(c), TEM micrograph (d) and elemental mapping (e-e3) of Forsterite nanoparticles.
In our previous study, Forsterite nanoparticles were synthesized through sol-gel method in an acidic medium
without using a surfactant, followed by calcination at 900 °C [38]. However, it was found that there was an
undesired phase in the XRD pattern of Forsterite nanoparticles, the Enstatite phase. Moreover, the
microstructural results showed that the Forsterite nanoparticles synthesized in the acidic medium had a
spherical morphology in combination with dendrite-like particles. The difference in morphology can be related
to biphasic structure of Forsterite synthesized in that study. Herein, the Forsterite nanoparticles were
synthesized through CTAB-assisted sol-gel method in an alkaline medium. It was recommended that the
surfactant in the synthesis medium is capable of yielding the final product with smaller particles size, which can
also affect the textural properties to produce the mesoporous structure [73,74]. Moreover, yielding a ceramic
material with smaller particle size in the presence of a surfactant was proven to decrease the crystallization
temperature of final product, which is why the Forsterite nanoparticles synthesized here were single-phase and
pure [75,76].

3.7. Surface modification of the Gehlenite scaffold

The Gehlenite scaffold sintered at 1375 °C with desired physical properties was chosen to be coated by the
polymer-ceramic nanocomposite. The PCL/Forsterite nanocomposite was designed to not only strengthen the
mechanical properties of Gehelnite scaffold, but also to improve the bioactivity and biological-related properties
of scaffold. In the first step and before getting the surface modification started, there is a requirement to find an
appropriate concentration for both PCL and Forsterite nanoparticles. Four PCL concentrations (4, 6, 8 and
10 wt.%) were first carefully applied on the scaffold to find the maximum concentration by which a complete
coating without clogging the macroporous structure can be obtained. Fig. 8 indicates the SEM micrographs of

non-coated Gehlenite scaffold (Fig. 8(a-a2)), PCL-coated scaffold (4 wt.%, Fig. 8(b-b2)), PCL-coated scaffold
(6 wt.%, Fig. 8(c-c2)), PCL-coated scaffold (8 wt.%, Fig. 8(d-d2)) and PCL-coated scaffold (10 wt.%, Fig. 8(e-e2)). By
looking at the non-coated Gehlenite scaffold’s micrographs and the coated scaffolds, it is easy to distinguish the
PCL membrane-like coating on the surface. Through the SEM micrographs, it was found that a delamination
after PCL coating occurred. The signs of delamination from the starting concentration is visible, but it is
observable that besides delamination, using 4 wt.% was not enough to coat the surface completely (Fig. 8(b-b2)).
Interestingly, increasing in the PCL concentration up to 6 wt.% was accompanied by a more effective coating all
over the surface (Fig. 8(c-c1)), and specifically, Fig. 8(c2) clearly shows that the struts were fully covered with a
porous PCL coating. It should be mentioned from this concentration, PCL membranes started to act like a curtain
to clog the macroporous structure of scaffold.

Fig. 8. The SEM micrographs of non-coated Gehlenite scaffold (sintered at 1375 °C) (a-a2) and PCL-coated
scaffolds with different PCL wt.% including 4 (b-b2), 6 (c-c2), 8 (d-d2) and 10 (e-e2).
Speaking of prioritization, our first goal here was reaching a concentration that completely covers the surface,
followed by preventing the macropores to be clogged. However, as can be seen in Fig. 8(c), some of the
macropores were clogged. It is noteworthy that through the SEM observations, the surface of PCL-coated
scaffold (6 wt.%) was carefully observed and our visual observations implicated that most of the macropores in
this scaffold were intact. Raising the concentration up to 8 wt.% obviously blocked more porous structure (Fig.
8(d-d2)), and eventually, 10 wt.% was the concentration by which most of the macropores of scaffold were
clogged, impeding the diffusion of nutrients in the inner parts of scaffold to support the cells growth [7].
Therefore, the optimized PCL concentration here is 6 wt.%, and the Forsterite nanoparticles were added to
6 wt.% of PCL, which will be discussed in the next paragraph.

After optimization of the PCL concentration, it was Forsterite’s turn to be optimized. Finding a suitable Forsterite
concentration means increasing the ceramic concentration to a maximum extent by which the surface of PCLcoated scaffold was blanketed by the nanoparticles. Fig. 9 exhibits the SEM micrographs of PCL/Forsterite
nanocomposite-coated scaffold (5 wt.%, Fig. 9(a-a3)), PCL/Forsterite nanocomposite-coated scaffold (7 wt.%, Fig.
9(b-b3)), PCL/Forsterite nanocomposite-coated scaffold (9 wt.%, Fig. 9(c-c3)) and PCL/Forsterite nanocompositecoated scaffold (11 wt.%, Fig. 9(d-d3)). Compared to the previous figure, it is distinguishable that the addition of
5 wt.% Forsterite nanoparticles to the PCL matrix significantly decreased the porous membrane-like structure of
PCL. However, through higher magnifications, it is clearly observable that the Forsterite nanoparticles were
accumulated in the PCL matrix in a sporadic way (Fig. 9(a3)) and there was a definite need to increase the
Forsterite’s concentration. It can be seen that increasing the concentration up to 11 wt.% was synchronized with
complete coverage of the surface of scaffold which is highly desirable for biological-related applications [77].
Therefore, in this section, the appropriate concentrations of both PCL and Forsterite nanoparticles were found
to be 6 and 11 wt.%, respectively.

Fig. 9. The SEM micrographs of PCL/Forsterite nanocomposite-coated with different Forsterite wt.% including 5
(a-a3), 7 (b-b3), 9 (c-c3) and 11 (d-d3).
Through the next sections, non-coated Gehlenite scaffold (1375 °C), PCL (6 wt.%)-coated Gehlenite scaffold and
PCL (6 wt.%)/Forsterite (11 wt.%) nanocomposite-coated Gehlenite scaffold are applied in different biologicalrelated tests including bioactivity, degradation, cell viability, attachment and proliferation in vitro. Putting these
scaffolds into the tests simultaneously provides more precise information about the effects of each composition
of surface coating.

3.8. Characterization of non-coated and coated Gehlenite scaffolds

Structure, chemical bonds, compressive strength, and porosity of non-coated, PCL-coated and PCL/Forsterite
nanocomposite-coated scaffolds were assessed and discussed in this section. Moreover, a SEM micrograph plus
EDS analysis of PCL/Forsterite nanocomposite-coated scaffold are provided. The XRD patterns of non-coated,
PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds are indicated through Fig. 10(a). Moreover, the
PCL and Forsterite XRD patterns are also provided in the same figure.

Fig. 10. The XRD patterns (a), FTIR patterns (b), compressive vs. porosity (c) of non-coated, PCL-coated and
PCL/Forsterite nanocomposite-coated scaffolds; the SEM micrograph (d), EDS analysis (d1) and elements
percentages (d2) of PCL/Forsterite nanocomposite-coated scaffold.
The reason for utilizing XRD here was to provide evidence that PCL and Forsterite were coated on the Gehlenite
scaffold. It can be seen that PCL XRD pattern solely contains two distinguishable peaks at 21.37° and 23.58°.
After coating of the Gehlenite scaffold by PCL, the main peak of PCL XRD pattern (21.37°) appeared in the
pattern of PCL-coated scaffold, which is indexed in the figure. Another distinguishable fact is a decrease in the
intensity of all XRD peaks of Gehlenite after PCL coating, which can be attributed to the existence of polymer
coating, prevent X-ray diffusion effectively. After addition of Forsterite in the composition of surface coating,
some new peaks were appeared in the XRD pattern of PCL/Forsterite nanocomposite-coated scaffold, which are
indexed to be Forsterite.
The FTIR spectra of non-coated, PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds are exhibited
through Fig. 10(b). There are generally five FTIR peaks relating to the chemical bonds of Gehlenite. The bands at
646 and 709 cm−1 were attributed to the bending vibrations of Si-O and Si-O-Al, respectively [78,79]. The bands
at 805 and 918 cm−1 were ascribed to the stretching vibrations of Al-O, and the band at 1023 cm−1 related to the
stretching vibrations of Si-O-Si [28,76]. There are two other peaks left in the FTIR spectrum of non-coated
scaffold, which are the bands at 1604 and 3423 cm−1 that related to bending and stretching vibrations of OH
groups, respectively [35]. It is worth noting that the PCL/Forsterite nanocomposite can be bonded to the surface
hydroxyl groups (OH) of Gehlenite scaffold through hydrogen bonding.
Coating of PCL on the Gehlenite scaffold was synchronized with the appearance of some new bands, all of which
were considered as the typical characteristic peaks of PCL. The most intensive peak at 1730 cm−1 belonged to the
carbonyl stretching mode. The bands at 2869 and 2948 cm−1 were attributed to the symmetric and asymmetric
stretching of CH2 groups [80]. The two peaks at 1167 and 1241 cm−1 corresponded to the stretching vibrations of
C_O_C, and the other peak at 1294 cm−1 related to the stretching vibrations in the crystalline phase of PCL [81].
The addition of Forsterite to the coating’s composition had some minor effects on the FTIR spectrum of
PCL/Forsterite nanocomposite-coated scaffold, like small shifting of some peaks due to overlapping of the
Forsterite bands and the other bands relating to both PCL and Gehlenite.
Fig. 10(c) shows the compressive strength and porosity values of non-coated, PCL-coated and PCL/Forsterite
nanocomposite-coated scaffolds, where a significant increase in the compressive strength of non-coated
Gehlenite scaffolds occurred after coating of PCL. The initial compressive strength value of non-coated scaffold
was 0.8 MPa, which was raised up to 2.5 MPa after coating process with PCL. Notably, coating of PCL with the
optimized value (6 wt.%) just decreased 11 % of the total porosity of non-coated scaffold (81 %) and the porosity
of PCL-coated scaffold was 70 %, which is high enough to support cell growth [7]. The obtained results of
porosity are in good agreement with Fig. (8), in which the optimized PCL concentration was found to be high
enough to coat the surface completely without blocking most of the macroporous structures. It should be
mentioned that the addition of Forsterite to the coating’s composition yielded 2.52 MPa and 68 % as the

compressive strength and porosity, respectively. It was also revealed that the addition of Forsterite did not
affect the PCL-coated scaffold’s porosity in a negative way, as shown through Fig. 9(d), which shows the
macropores are intact after addition of 11 wt.% Forsterite nanoparticles.
Fig. 10(d-d2) contains a SEM micrograph relating to PCL/Forsterite nanocomposite-coated scaffold plus EDS
analysis, weight and atomic percentages of this sample. These figures (Fig. 10(d-d2)) clearly show that some new
elements were detected besides the Gehlenite structural elements and these elements including Mg, Si and C
were attributed to the Forsterite and PCL.

3.9. In vitro bioactivity

As proposed by Kokubo et al. [50], assessment of in vitro bioactivity through immersion of a biomaterial into SBF
would simulate its bioactivity in vivo, so both the number of animals and duration of experiments for in
vivo studies can be significantly decreased. Although there is some criticism relating to this method to anticipate
bioactivity in vivo [82], it was reported that the majority of studies conducting this in vitro method to see if their
intended biomaterials were bioactive received the same answer through the in vivo study, showing that this
method is trustworthy [83]. In this section, the in vitro bioactivity behavior of non-coated, PCL-coated and
PCL/Forsterite nanocomposite-coated scaffolds was assessed up to 21 days soaking into SBF. The results include
SEM micrographs and EDS analyses of each sample after 7, 14 and 21 days soaking into SBF, which are indicated
through Fig. 11(a-i3). It should be mentioned that the EDS analyses of non-coated and PCL-coated scaffolds were
taken just after 21 days immersion into SBF, but in the case of PCL/Forsterite nanocomposite-coated scaffold,
the EDS analyses were taken after 7 and 21 days soaking into SBF. Due to the similarity in the morphology of
Forsterite and newly formed precipitates it was hard to distinguish one from the another, so taking the EDS
analysis after 7 days would better reveal if a new element besides the others was detected. Nonetheless, the
ions concentrations and pH of SBF solutions in which the scaffolds had been soaked, were measured through ICP
and pH meter, respectively, and the results are exhibited in Fig. 12.

Fig. 11. The SEM micrographs and EDS analyses of non-coated (a-c2), PCL-coated (d-f2) and PCL/Forsterite
nanocomposite-coated scaffolds (g-i3) after soaking into simulated body fluid for different time periods.

Fig. 12. The plots of Al3+ (a), Ca2+ (b), Si4+ (c), PO43− (d) and Mg2+ (e) ions concentrations and pH variations (f) of
non-coated, PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds in simulated body fluid for different
time periods.
Fig. 11(a-c1) indicates the SEM micrographs of non-coated scaffold after being immersed into SBF up to 21 days.
As seen, even after 21 days, there were some precipitates that were distributed sporadically. Taking an EDS
analysis from the precipitates revealed that besides the other elements, P was also detected (Fig. 11(c2)). It is
worth mentioning that PO43− ions have a strong affinity to go through reaction with Ca2+ to form calcium
phosphate, so detection of P here indicated that through the precipitates, there were calcium phosphate
particles [79]. Through Fig. 12 and in the case of non-coated scaffold, it is visible that Al3+ and Ca2+ ions were
released with a relatively gentle slope, but the release rate of these ions from the non-coated scaffold was the
most among all scaffolds. On the other hand, PO43− and Mg2+ ions experienced a downward trend, showing that
they were consumed and precipitated on the non-coated scaffold. The pH trend of non-coated scaffold showed
an upward trend up to 21 days and finally reached 7.8.
Fig. 11(d-f2) indicates the SEM micrographs of PCL-coated scaffold after 7, 14 and 21 days soaking into SBF plus
the EDS analysis of precipitates after 21 days. Similar to the non-coated scaffold, the PCL-coated scaffold was
not capable of forming huge amounts of newly formed precipitates on itself. After 21 days soaking, some
particles were deposited on the surface of scaffold, but they were not high enough to cover the surface

completely. It is noteworthy that P was detected by the EDS analysis as well (Fig. 11(f2)). In the case of ions
liberation, PCL coating on the scaffold was synchronized with a decrease in the release rate of Al3+, Ca2+ and
Si4+ ions compared to the non-coated scaffold. Moreover, the consumption rate of PO43− and Mg2+ ions were
slower that the non-coated scaffold. The reason why this phenomenon was seen stemmed from the impeding
effect of PCL coating causing the ions to be released slower than the non-coated scaffold. The slower
consumption rate also showed that less ions exchange occurred between the PCL-coated scaffold and its
surrounding medium, resulting in weaker bioactivity compared to the non-coated scaffold. The PCL-coated
scaffold’s pH trend seems to experience the least amount of variation than the other scaffolds. The results of
PCL-coated scaffold’s in vitro bioactivity here are in good agreement with the previous studies, reporting that
although PCL as a biodegradable polymer has great mechanical properties than other degradable polymers, its
hydrophobic nature prevents fast and effective deposition of carbonated-apatite after being soaked into SBF
[40,84].
The PCL/Forsterite nanocomposite-coated scaffold’s SEM micrographs after 7, 14 and 21 days soaking into SBF
and the EDS analyses are exhibited through Fig. 11(g-i3). Notably, for each time interval, three SEM micrographs
are provided. One of the mentioned micrographs was formed with backscattered electrons (BSE) and the others
formed with secondary electrons (SE). The BSE micrographs were taken in a lower magnification to reveal the
quantity of newly formed precipitates. Nonetheless, different to the other scaffolds, two EDS analyses are
provided for this sample after 7 and 21 days soaking into SBF. Through our observations, it was found that in the
early soaking time of PCL/Forsterite nanocomposite-scaffolds into SBF, the scaffolds were buried in huge
amounts of newly formed precipitates. Therefore, as mentioned before, due to similarity in the morphology of
Forsterite nanoparticles and newly precipitates, it has been decided to provide the EDS analysis of scaffold after
7 days to detect P along with the other elements, as a sign of calcium phosphate precipitation.
Through the BSE micrographs, it is clear that newly formed precipitates were increased significantly after 21
days soaking into SBF. Moreover, the change in morphology of deposited particles by passing time is
distinguishable. After 7 days, it is clear that these particles were small in size and there were interparticle
porosities visible between them. Up to 21 days, the particles size increased followed by changing in the
morphology to cauliflower-like and the density increased as well. The results of SEM micrographs clearly showed
the crystallization trend of deposited calcium phosphate particles through soaking time and the obtained results
are in good agreement with the ICP results; the Al3+ ions concentrations were nearly zero up to 21 days,
indicating that the PCL/Forsterite nanocomposite coating prevented their release from the surface of Gehlenite
scaffold. The Ca2+ and PO43− release trends, on the other hand, experienced a constant decrease with a deep
slope, showing that they were consumed to form calcium phosphate particles on the surface of scaffold. The
Mg2+ and Si4+ ions had upward trends up to 21 days resulting from the existence of Forsterite as a magnesium
silicate ceramic in the coating composition and its ions exchange with its surrounding medium. The pH trend of
PCL/Forsterite nanocomposite-coated scaffold experienced the most increase among the all scaffolds and finally
reached 8.1.
The in vitro bioactivity mechanism of PCL/Forsterite nanocomposite-coated scaffold can be described as follows:
first, an ion exchange between the Mg2+ ions of Forsterite (Mg2SiO4) and H3O+ ions of SBF occurs, resulting in an
pH increase followed by SBF alkalinity. Based on previous studies, a pH in the range of 7.5–8 provides an ideal
environment in which carbonated-apatite precipitation and crystallization can occur [85,86]. After initial ions
exchange, a negatively-charged silica gel layer forms, followed by providing an ideal situation for calcium
hydroxyl phosphate precipitation. Eventually, the newly formed precipitates will be crystallized by passing the
soaking time to form calcium-deficient carbonated-apatite [87]. Through this section, it was found that although
PCL increased the mechanical properties of Gehlenite scaffold, it weakened the scaffolds bioactivity in vitro,
which is why the addition of Forsterite nanoparticles in the nanocomposite’s composition was necessary. The

nanocomposite coating on the Gehlenite scaffold yielded a significant increase in not only the quantity of
calcium phosphate precipitations, but also in their deposition kinetic.

3.10. In vitro degradation

The in vitro degradation behavior of non-coated, PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds
was assessed through immersion of the scaffolds into PBS and CAB up to 28 days. The results are indicated
through Fig. 13, containing the weight variations (%) of scaffolds after being immersed into the buffers plus
determining the pH changes of buffers during soaking period. As seen through Fig. 13(a), there are two trends
visible—the first being a slight increase in the weight of non-coated scaffold up to 21 days followed by a drop at
the end of line, and the other trend being a constant rate relating to both PCL-coated and PCL/Forsterite
nanocomposite-coated scaffolds. The pH values of scaffolds after being immersed into PBS are exhibited in Fig.
13(b). It is obvious that the non-coated scaffold increased the pH of PBS up to 7.9 at the early days of soaking,
providing an appropriate condition for precipitation of different ions of PBS [85]. It is noteworthy that once a
material is soaked into a buffer solution like PBS, there are two main reactions—degradation and precipitation—
competing with each other [51]. It can be justified that the non-coated scaffold gained 3.5 % weight up to 21
days due to the prevailing of precipitation over degradation reaction. However, after 28 days of soaking, the
scaffold lost 5.5 %, showing that the degradation reaction dominated the precipitation.

Fig. 13. The weight variation percentage (%) of non-coated, PCL-coated and PCL/Forsterite nanocompositecoated scaffolds, and pH changes during soaking into phosphate buffer saline (a and b) and citric acid buffer (c
and d) at different time intervals.
The variation in coated scaffolds’ weight was less than the non-coated scaffold, but both of them experienced a
slight decrease in their weights up to 14 days, followed by an increase in their weights up to 28 days. This
behavior for both PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds revealed that the degradation

reaction was the dominant factor up to 14 days, then everything became the reverse up to 28 days. It is
important to take their pH variations into account as well. It was determined that the pH variation of PCL-coated
scaffold was the least among the all scaffolds, and at the end of line, the pH reached 7.63. However, the pH
trend of PCL/Forsterite nanocomposite-coated scaffold exhibited a sharp increase up to 10 days and it reached
10, due to high amounts of OH− ions; a high rate of precipitation was probable [34,54]. There is a logical reason
behind this phenomenon; as mentioned before, the degradation rate prevailed over precipitation up to 14 days,
and the pH increased significantly up to 10 after 14 days, then it became nearly steady. It can be said that the
degradation caused the huge release of Mg2+ ions, which have a great potential to raise the pH towards alkaline
medium [88]. Then the high pH yielded the fast reaction of Mg2+ and OH− ions, resulting in the consumption of
OH− ions, which is the reason why the aggressive pH trend was controlled.
Fig. 13(c and d) shows the weight and pH variations of scaffolds after being soaked into CAB. The very first thing
to take into consideration is the effect of PCL coating on the degradation behavior of Gehlenite scaffold. The
non-coated scaffold constantly lost its weight into CAB up to 28 days, and at the end of line, this sample’s weight
decreased down to 70 %. However, the PCL-coated scaffold exhibited a slower decreasing trend and finally lost
nearly 30 % of its initial weight, showing that PCL significantly increased the Gehlenite scaffold’s degradation
resistance in vitro. It should be mentioned that the pH trend of PCL-coated scaffold soaked into CAB increased
constantly up to 28 days, but its pH trend was, again, the least compared to the other scaffolds. In the case of
PCL/Forsterite nanocomposite-coated scaffold, in the early days of soaking, a drop—just like the non-coated
scaffold—is visible, followed by a decreasing in the degradation rate up to 28 days. The difference between this
scaffold and PCL-coated scaffold was the presence of Forsterite in the coating composition. Therefore, it can be
justified that during the early days of soaking, the Forsterite nanoparticles started to degrade very quickly
(pH = 3), which is why a drop in the weight of this scaffold was seen. Then, the degradation of Forsterite
nanoparticles caused the pH to increase up to 5, which is less harsh than 3 and so the PCL/Forsterite
nanocomposite-coated scaffold experienced a slower degradation rate up to 28 days.

3.11. In vitro cell compatibility and bioactivity in the cell culture medium

The cell viability of non-coated, PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds were assessed
by MTT assay up to 7 days, and the results are shown in Fig. 14, where from the first day it is visible that the cell
viability of non-coated and PCL/Forsterite nanocomposite-coated scaffolds were higher than both the negativecontrol and PCL-coated scaffold. It should be mentioned that the negative-control was the cell culture medium
containing the MG63 cells without being exposed to any scaffold. Continuing the assay up to 3 days gave the
same results of the first day, but this time the difference between the scaffolds became more evident; the
PCL/Forsterite nanocomposite-coated scaffold had the most cell viability not only among the all scaffolds, but
also compared to the negative-control. After 7 days, it was found that the scaffolds had higher cell viabilities
than the negative-control, showing the cell compatible essence of them.

Fig. 14. The cell viability of MG63 cells after 1, 3 and 7 days of incubation on non-coated, PCL-coated and
PCL/Forsterite nanocomposite-coated scaffolds (one-way ANOVA, black star denotes P ≤ 0.05).

The cell viability difference between the scaffolds can be described in this way; through previous sections, the
cell viability of non-coated scaffold sintered at 1375 °C was shown to be higher than the negative-control.
Herein, it was found that PCL coating on the scaffold affected the cell viability of substrate in a negative way,
and this phenomenon has rooted in the preventive effects of PCL in the ions liberations from the substrate.
Through Fig. 12, it is indicated that PCL coating caused the non-coated scaffold to release less ions, so the
decrease in the cell viability of PCL-coated scaffold was attributed to the PCL. Nonetheless, the significant
difference between the cell viability of PCL/Forsterite nanocomposite-coated scaffold and the other scaffolds
plus negative-control can be found in the stimulatory effects of Mg2+ and Si4+ ions on the osteoblasts cells. It was
reported through previous studies that Mg2+ and Si4+ ions are capable of improving osteoblast cells proliferation
and differentiation [89,90].
The cell attachment and proliferation of non-coated, PCL-coated and PCL/Forsterite nanocomposite-coated
scaffold were assessed after 1 and 7 days and indicated through Fig. 15. Moreover, the cells’ attachment and
density were assessed through DAPI staining as well, and the fluorescent images of DAPI staining are added
below the SEM micrographs of each scaffold at each time interval (Fig. 15). It is observable that all scaffolds
provided an appropriate surface on which the cells were attached and spread well. After the first day of cell
culture, it is visible through Fig. 15(a-a2) that a cell was spread on the densified surface through widening itself
to fix its position. On the other side, the attached cells on the PCL-coated and PCL/Forsterite nanocompositecoated scaffolds had a great tendency to highly widen themselves to form a membrane-like morphology with
pseudopodia anchored to the micro-porosities of both surfaces (Fig. 15(b-b2 and c-c2)).

Fig. 15. The SEM micrographs and fluorescent images of MG63-attached scaffolds after 1 day: non-coated (a-a3),
PCL-coated (b-b3), PCL/Forsterite nanocomposite-coated-coated scaffolds (c-c3), and 7 days: non-coated (d-d3),
PCL-coated (e-e3), PCL/Forsterite nanocomposite-coated-coated scaffolds (f-f3).
It is noteworthy that as it was indicated through Fig. 8, Fig. 9, the porous structure of PCL coating all over the
scaffold’s surface was visible and the PCL/Forsterite nanocomposite-coated scaffold’s surface contained lots of
interparticle porosities, both of which provided a suitable situation for better anchorage of the attached cells
[91]. Fig. 15(a3, b3, and c3) exhibits the fluorescent images of non-coated, PCL-coated and PCL/Forsterite
nanocomposite-coated scaffolds through which it is observable that the cells were accumulated well on the
scaffolds. After 7 days of cell culturing, the proliferation of cells on the scaffolds became more evident through
forming a huge matrix containing lots of cells (Fig. 15(d-f3)). Through Fig. 15(e and e1), clearly the nucleus of cells
and a circle-like membrane around them are obvious, which supports our claim that these huge matrices were
formed by a quite number of MG63 cells. The fluorescent images after 7 days (Fig. 15(d3, e3, and f3)) show that
the accumulation of cells on the PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds was higher than
the non-coated scaffold.
As it was introduced through the in vitro bioactivity section of non-coated and surface-coated scaffolds,
bioactivity assessment based on soaking the scaffolds into SBF is a trustworthy method by which many studies

have witnessed the in vitro bioactivity results were repeated through their in vivo experiments again [83].
However, it sounds more logical to simulate the in vivo conditions as closely as possible, so assessment of
bioactivity into the cell culture medium was reported to be an appropriate environment for the test [92].
Assessment of the scaffolds’ bioactivity in DMEM in the exposure of cells, which have an interaction with each
other, and organic additives would give us more realistic information about the scaffolds. The SEM micrographs
and EDS analyses of non-coated, PCL-coated and PCL/Forsterite nanocomposite-coated scaffolds after being
immersed into the cell culture medium in the exposure of cells up to 7 days are indicated through Fig. 16(a-c3).
After 7 days soaking into DMEM, it can be seen that some precipitates were formed on the non-coated scaffold,
whereas after being immersed into SBF (Fig. 11(a and a1)), this scaffold did not form as much as newly formed
precipitates compared to soaking into DMEM (Fig. 16(a-a2)). Through Table 1, the results revealed that the ions
liberations from the non-coated scaffold (sintered at 1375 °C) after being soaked into DMEM were significantly
higher than the SBF. Moreover, it was mentioned there that DMEM-containing the cells were proven to have a
more corrosive environment compared to the buffer solution [68]. Therefore, the more formation of
precipitates can be attributed to more degradation, which releases more ions to go to reaction with themselves
and other ions in the DMEM.

Fig. 16. The SEM micrographs and EDS analyses of non-coated (a-a3), PCL-coated (b-b3), and PCL/Forsterite
nanocomposite-coated scaffolds (c-c3) after soaking into Dulbecco's Modified Eagle Medium after 7 days.
The EDS analysis of non-coated scaffold is shown in Fig. 16(a3), where besides Ca, Si, Al and O elements, Na and
Cl elements were also detected. In the case of PCL-coated scaffold, some precipitates were found; but similar to
immersion into SBF, they were distributed sporadically. Speaking of the quantity, the newly formed precipitates
on the PCL-coated scaffold after being soaked into DMEM were higher than the SBF environment. The EDS
analysis from the newly formed particles showed that they contain Ca, Si, Al and O. The SEM micrographs of
PCL/Forsterite nanocomposite-coated scaffold in different magnifications are exhibited through Fig. 16(c-c2),
where the surface was covered with newly formed particles. It should be mentioned that by doing a comparison
between Fig. 9(d3) and (c2), which were taken in a similar magnification, it is visible that the surface of scaffold
before immersion into any medium was uniform, but after being immersed into DMEM it can be seen that newly
formed particles were deposited on the surface. However, due to lack of PO43− ions into DMEM, the EDS analysis

of PCL/Forsterite nanocomposite-coated scaffold mainly detected Ca, Si, Al, Mg, C and O, which could be
liberated and again precipitated on the scaffold.

4. Conclusion
This is a comprehensive study focusing on the fabrication of highly porous Gehlenite scaffolds (Ca2Al2SiO7) for
the first time, both with and without surface modification. A range of sintering temperatures was applied to find
the best one yielding the scaffold with both desired mechanical properties and an interconnected porosity. The
optimized sintering temperature was found to be 1375 °C, and this scaffold was then surface modified by a
polymer-ceramic nanocomposite. The coating’s composition included polycaprolactone (PCL) and Forsterite
(Mg2SiO4) nanoparticles. A range of different PCL and Forsterite concentrations were used separately to find an
optimized concentration that completely covered the surface of scaffold without blocking the macroporous
structure. A comparative investigation was accomplished between the non-coated, PCL-coated and
PCL/Forsterite nanocomposite coated scaffolds to recognize carefully the effects of PCL and Forsterite on the
physical, chemical and biological-related properties of Gehlenite scaffolds in vitro. Our results revealed that PCL
(6 wt.%)-Forsterite (11 wt.%) nanocomposite-coated Gehlenite scaffold (sintered at 1375 °C) has a great
potential for bone tissue regeneration.
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